| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
| IGF1R |
P08069
|
insulin like growth factor 1 receptor
|
Kinase
|
0.97 |
0.399 |
0.885 |
| IGF2 |
P01344
|
insulin like growth factor 2
|
|
4.4E-02 |
0.390 |
0.885 |
| IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| MAD2L2 |
Q9UI95
|
mitotic arrest deficient 2 like 2
|
|
8.2E-02 |
0.547 |
0.731 |
| NFIX |
Q14938
|
nuclear factor I X
|
Nucleic acid binding
|
1.00 |
0.547 |
0.769 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| PCLO |
Q9Y6V0
|
piccolo presynaptic cytomatrix protein
|
|
1.00 |
0.656 |
0.577 |
| PRTN3 |
P24158
|
proteinase 3
|
Enzyme
|
3.8E-05 |
0.503 |
0.808 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |
| RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
| RFWD3 |
Q6PCD5
|
ring finger and WD repeat domain 3
|
Enzyme
|
3.5E-10 |
0.569 |
0.731 |
| RTTN |
Q86VV8
|
rotatin
|
|
9.0E-34 |
0.619 |
0.654 |
| SLX4 |
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
1.6E-22 |
0.565 |
0.731 |
| TGFBR2 |
P37173
|
transforming growth factor beta receptor 2
|
Kinase
|
0.13 |
0.413 |
0.846 |
| TSHR |
P16473
|
thyroid stimulating hormone receptor
|
G-protein coupled receptor
|
3.0E-15 |
0.486 |
0.808 |
| UBE2T |
Q9NPD8
|
ubiquitin conjugating enzyme E2 T
|
|
1.1E-05 |
0.550 |
0.731 |
| WDR4 |
P57081
|
WD repeat domain 4
|
Nucleic acid binding
|
1.4E-08 |
0.653 |
0.538 |
| XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |